Atooppinen Ihottuma
EADV 2025 with Sanofi: Advanced Dermatology Resources
Discover Sanofi at EADV2025 featuring BioDay registry findings, expert panels, and networking opportunities for dermatology professionals in Paris.
Campus
- Tuotteet
- Act-HIB®
- Aldurazyme®
- Apidra®
- Aubagio®
- Beyfortus®
- Cablivi®
- Cerdelga®
- Cerezyme®
- Dupixent®
- Dupixent® CRSwNP
- Dupixent® Prurigo Nodularis
- Dupixent® Asthma
- Efluelda®
- Fabrazyme®
- Imovax Polio®
- Insulin aspart Sanofi®
- Insulin lispro Sanofi®
- Jevtana®
- Kevzara®
- Lantus®
- Lemtrada®
- Myozyme®
- Nexviadyme®
- Praluent®
- Rabies Imovax®
- Stamaril®
- Tetravac®
- Toujeo®
- Triaxis®
- Typhim Vi®
- Vaxigrip Tetra®
- Tyypin 1 diabetes
Campus
- Tuotteet
- Act-HIB®
- Aldurazyme®
- Apidra®
- Aubagio®
- Beyfortus®
- Cablivi®
- Cerdelga®
- Cerezyme®
- Dupixent®
- Dupixent® CRSwNP
- Dupixent® Prurigo Nodularis
- Dupixent® Asthma
- Efluelda®
- Fabrazyme®
- Imovax Polio®
- Insulin aspart Sanofi®
- Insulin lispro Sanofi®
- Jevtana®
- Kevzara®
- Lantus®
- Lemtrada®
- Myozyme®
- Nexviadyme®
- Praluent®
- Rabies Imovax®
- Stamaril®
- Tetravac®
- Toujeo®
- Triaxis®
- Typhim Vi®
- Vaxigrip Tetra®
- Tyypin 1 diabetes